The Tightening Fed, Geopolitics And Order In The S&P 500
Apr 20, 2017Jeremy Parkinson0
The U.S. stock market has, for the most part, behaved in a very orderly fashion since the first quarter of 2016 ended just over a year ago. But since 1 March 2017, when the S&P 500 reached its all-time record peak closing value of 2,395.96, the S&P 500 has dropped diagonally by three standard deviations […]
Sterling Retraces Tuesday’s Gains Though Short Squeeze May Continue
Apr 20, 2017Jeremy Parkinson0
Video length: 00:28:59 Wednesday appeared to be a day of retracing Tuesday’s large moves with one exception. Canadian Dollar weakness continued as USD/CAD traded at its highest level in over a month after the weekly EIA numbers in the US showed that Gasoline Stockpiles rose for the first time in 9-weeks. USD/CAD was supported by the retracement higher in […]
EUR/USD Extends Gains On French Polls, USD Weakness
Apr 20, 2017Jeremy Parkinson0
EUR/USD is on the rise once again, extending the recent gains and reaching the highest levels during the month of April, reaching a high of 1.0747. These recent gains are an extension of the bounce within the uptrend channel. Further resistance awaits at 1.0775 and 1.0830. Why is EUR/USD rising? Looking at other charts, it is […]
Sensex & Nifty Open Flat; Yes Bank Slips 3.5% Post Q4 Results
Apr 20, 2017Jeremy Parkinson0
Stock markets in Asia are higher today following key earnings on Wall Street and as oil prices came off two-week lows set earlier in the session. The Shanghai Composite is up 0.13%, while the Hang Seng is up 0.35%. The Nikkei 225 is trading higher by 0.31%. The US equities closed mostly lower on Wednesday, with IBM and oil prices pushing down […]
Gold Reverses Gains – Thursday, April 20
Apr 20, 2017Jeremy Parkinson0
Gold prices moved lower on Wednesday as the greenback clawed back some of its recent losses. “Economic activity increased in each of the twelve Federal Reserve Districts between mid-February and the end of March, with the pace of expansion equally split between modest and moderate… Employment expanded across the nation and increases ranged from modest […]
Above The 40 – Stock Market Stasis
Apr 20, 2017Jeremy Parkinson0
AT40 = 47.2% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 60.1% of stocks are trading above their respective 200DMAsVIX = 14.9 (volatility index)Short-term Trading Call: cautiously bullish) Commentary The S&P 500 (SPY) ended last week on a sour note. The index hit its first 42 trading day low since the days going into […]
Goldman Pours Cold Water On Trump’s Fiscal Stimulus Plan
Apr 20, 2017Jeremy Parkinson0
Goldman Sachs’ Chief US Political Economist Alec Phillips writes that tax reform faces a risk of failure, but tax cuts remain likely… in 2018 and investors need to stay realistic about the impact of fiscal stimulus. President Trump’s campaign proposals initially raised expectations of several forms of fiscal stimulus, driving investor optimism on both infrastructure spending and […]
Creating A College Savings Plan For Your Kids
Apr 20, 2017Jeremy Parkinson0
It was brought to my attention that I ought to write a piece to help some of my peers with this struggle… Many Millennials are starting families, and even though their kids are facing an uncertain monetary future when it comes to retirement, the least that parents can do is insure that they have […]
NZD/USD Cannot Break Out Of Range Despite CPI Jump
Apr 20, 2017Jeremy Parkinson0
Prices in New Zealand surged by 1% in Q1 2017, above 0.8% expected and a much slower 0.4% that was reported in Q4 2016. Year over year, we also had a beat of 0.2%: CPI is up 2.2% against 2% expected. The kiwi did react positively to the news, but it never went very far. NZD/USD reached […]
Ultragenyx Pharmaceutical Reports Positive Phase III Data For Their Kyowa Hakko Kirin-Partnered Drug
Apr 20, 2017Jeremy Parkinson0
Ultragenyx Pharmaceutical Inc. (Nasdaq: RARE) has reported clearly positive Phase III data for their Kyowa Hakko Kirin-partnered drug for X-linked hypophosphatemia, and now they plan to hustle that data package to regulators at the FDA and EMA. Written by John Carroll (ENDpts.com) Researchers recruited 134 patients for the study, and found that 94% of the patients […]